European Urology Open Science (Dec 2022)

Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?

  • Michele Marchioni,
  • Daniele Amparore,
  • Laura Marandino,
  • Riccardo Bertolo,
  • Selcuk Erdem,
  • Alexandre Ingels,
  • Stijn Muselaers,
  • Onder Kara,
  • Nicola Pavan,
  • Eduard Roussel,
  • Umberto Carbonara,
  • Angela Pecoraro,
  • Pietro Diana,
  • Alessio Pecoraro,
  • Riccardo Campi

Journal volume & issue
Vol. 46
pp. 39 – 42

Abstract

Read online

No abstracts available.